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Abstract
OBJECTIVE: To research the curative effect of Chi-
nese herbs for clearing away heat, promoting diure-
sis, nourishing the kidney, and consolidating es-
sence in children with Henoch-Schonlein purpura
nephritis (HSPN) with internal accumulation of
damp-toxin using randomized controlled observa-
tions on large samples. To seek the mechanism of
the therapy and its scope of indications.
METHODS: Overall, 186 children with HSPN were
randomly divided into two groups: treatment
group (n=126) treated with Chinese herbs for clear-
ing heat and promoting diuresis and a control
group (n=60) treated with Western Medicine. The
treatment was carried out for three courses of 4
weeks each. We recorded changes in patient urine
routines, 24 h urinary protein, blood-coagulating
series, immunoglobulin and T-cell subgroups, and
improvements in main symptoms. We evaluated
the alleviation of clinical symptoms and the im-
provement of proteinuria, hematuria, and other lab-
oratory test results. Finally, we analyzed the patient
population suitable for this therapy according to
the relationship between the grouping of patient
body weight and curative effect.
RESULTS: Damp-heat syndrome improved in the
treatment group, with a significant difference in to-
tal effective rate after a 4-week treatment (χ2=
13.5220, P=0.0002) and in curative rate after a
12-week treatment (χ2=6.3410, P=0.0118), com-
pared to those in the control group. The curative ef-
fect in the treatment group was greater than that
in the control group but there was no statistical dif-
ference between the two groups. The curative ef-
fect after a 4-week treatment of patients in the
treatment group weighing 30 kg or less based on
Traditional Chinese Medicine (TCM) signs and uri-
nary protein was significantly greater than that in
the control group. However, there was no statistical
difference in the curative effect on urinary red cells
and various indexes after a 12-week treatment be-
tween the two groups.
CONCLUSION: Therapy for clearing away heat, pro-
moting diuresis, nourishing the kidney, and consoli-
dating essence using TCM is effective in children
with HSPN from internal accumulation of
damp-toxin. The therapy is especially suitable for
patients weighing 30 kg or less. The curative effect
may be related to the improvement of immune
function and blood-coagulation.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Henoch-Schonlein purpura (HSP) is a systemic disease
characterized by leukocytic vasculitis of small vessels
and sediment of immunoglobulin A (IgA).1 Whether
the kidney is affected is crucial for the prognosis of
HSP in adolescent patients.2 When there is renal im-
pairment, it is called Henoch-Schonlein purpura ne-
phropathy (HSPN), which accounts for 78.9% of sec-
ondary glomerulopathy in children.3 The disease has a
long illness course and can easily relapse into life-threat-
ening late nephropathy in severe cases.4
According to our earlier research, we found that the rec-
ipe prescribed by professor Xueyi Pei (Traditional Chi-
nese Medicine Department, Beijing Children's Hospi-
tal affiliated to Capital Medical University) for promot-
ing diuresis, removing toxins, nourishing the kidney,
and consolidating essence has a curative effect and is
safe for HSPN in children.5-8 Therefore, we carried out
a randomized controlled trial with a large sample size
to study the curative effect of the recipe on HSPN. We
also aimed to explore the pathological features of and
curative effect on internal accumulation of damp-tox-
in, and seek the indications and mechanism of the ther-
apy. This study could provide fewer toxic side-effects,
standardize treatment, enhance curative effect, and
improve prognosis over standard therapy in HSPN
treatment.
METHODS
Diagnostic standard
Diagnostic standards in Western Medicine are stipulat-
ed in reference to the latest standards for diagnosing
HSPN and its classification in the evidence-based trial
guide for diagnosing and treating purpura nephritis
published in 2009 in the China Journal of Pediatrics.
The standards for diagnosing Traditional Chinese Med-
icine (TCM) syndromes are stipulated in reference to
the standards for diagnosing the syndrome of internal
accumulation of damp-heat issued in the Principle for
Instructing Clinical Research into New Chinese
Drugs.10
Inclusion standards
This trial was approved by the ethics committee of Bei-
jing Children Hospital. All participants' guardians gave
written informed consent in accordance with the Dec-
laration of Helsinki. Patients aged 5-16 years con-
formed to standards for diagnosing purpura nephritis
in Western Medicine and internal accumulation of
damp-heat in TCM. Hormones, cyclophosphamide,
Tripterygium glycosides tablet, mycophenolate mofetil,
and other immune inhibitors were not used 10 days be-
fore trial initiation.
Exclusion standards
Excluded from the trial were patients with 24 h uri-
nary protein quantity ≥3 g/d and/or ≥50mg/kg per 24 h,
insufficient liver, kidney, heart, brain, or other organ
function, or with abnormal urinary examination
caused by secondary nephritis, hypercalcinuria, hyper-
uricemia, or other diseases.
Randomization
Patients were randomly divided by a random number
table into a treatment group and a control group with
SAS 9.1.3 statistical software (vers 9.1.3, SAS Institute,
Chicago, IL, USA).
Therapies
Patients in the treatment group were treated with Chi-
nese medicinal decoction based on a prescription from
professor Xueyi Pei. The Chinese medicinal materials
were purchased and decocted by the pharmaceutical de-
partment of Beijing Children's Hospital. The decoc-
tion was taken orally twice a day, 50 mL for patients
weighing<20kg,or100mLforpatientsweighing ≥20 kg.
The recipe consists of: Fengweicao (Herba Pteridis Mul-
tifidae) 10-15 g, Yiyiren (Semen Coicis) 30 g, Kushen
(Radix Sophorae Flavescentis) 10 g, Shiwei (Folium Pyr-
rosiae) 12 g, Daokoucao (Herba Achyranthis Asperae)
15-30 g, Baijiangcao (Herba Patriniae Scabiosaefoliae)
10 g, Lianqiao (Fructus Forsythiae Suspensae) 10 g, Ch-
ishao (Radix Paeoniae Rubra) 10 g, Huangqi (Radix As-
tragali Mongolici) 10 g, Shanyao (Rhizoma Dioscoreae
Oppositae) 15-30 g, Puhuang (Pollen Typhae) 15 g, Li-
anxu (Stamen Nelumbinis) 10 g, Dandouchi (Semen
Sojae Preperatum) 12 g, Chixiaodou (Semen Vignae An-
gularis) 30 g, and Qianshi (Semen Euryales) 20 g. The
decoction clears damp-heat, nourishes kidney, and con-
solidates essence.
Patients with hematuria in the control group took di-
pyridamole orally (produced by Tianjin Lisheng Phar-
maceutical Co. Ltd. Tianjin, China), 3-5 mg/kg-1·d-1.
Patients with hematuria and proteinuria took dipyri-
damole and captopril orally (produced by Sino-US
Shanghai Shiguibao Pharmaceutical Co. Ltd., Shang-
hai, China), 1-2 mg/kg-1·d-1. All patients were treated
for three consecutive courses of treatment with 4 weeks
in each. If the illness condition was unimproved or fur-
ther aggravated after a 4 weeks treatment, the treat-
ment was terminated and the treatment was regarded
as ineffective.
Items and methods of observation
Observed indexes were urinary routine, urinary sedi-
ment, 24 h urinary protein, immunological indexes of
cells and body fluid, and blood-coagulating series. To-
tal scores for major and minor symptoms, signs,
tongue picture, and pulse condition of internal accu-
mulation of damp-heat syndrome were recorded after
1, 4, and 12 weeks of treatment.
Standards for improving TCM syndromes and judging
curative effect were drawn up in reference to the Princi-
ple for Instructing Clinical Research into New Chinese
Drugs and from clinical experience.
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Statistical methods
SAS statistics software (Version 9.1.3, SAS Institute,
Chicago, IL, USA) was used for statistical analysis.
P<0.05 (two sides) was regarded as statistically signifi-
cant. χ2 test, Fisher precise probability, and Wilcoxon
rank tests were used to process qualitative data. T-test
was used for quantitative data conforming to a normal
distribution, and rank test was used for quantitative da-
ta not conforming to a normal distribution. Spearman
relevant analysis test was used for analysis of relativity.
RESULTS
General condition
One hundred and eighty-six inpatients at the TCM de-
partment of Beijing Children Hospital from January
2010 to June 2012 were randomly divided into a treat-
ment group of 126 and a control group of 60. Three
patients (2.38% ) in the treatment group and four
(6.67%) in the control group were excluded because of
dropout, leaving 123 in the treatment group and 56 in
the control group. There were five patients with hema-
turia, 39 patients with proteinuria, and 135 patients
with hematuria and proteinuria.
There were no statistical differences (P>0.05) in age,
sex, illness course, total score of TCM syndromes, 24 h
urinary protein, skin purpura, or hematuria between
the two groups.
Analysis of curative effect
As shown in Table 1, the curative effect on TCM syn-
dromes in the treatment group was better than that in
the control group. There was a statistical difference in
total effective rate of 4 weeks treatment (χ2=13.5220,
P=0.0002) and curative rate of 12-week treatment be-
tween the two groups (χ2=6.3410, P=0.0118).
As shown in Table 1, the clinical curative effect and the
curative effect on hematuria in the treatment group
were better than those in the control group. However,
there was no statistical difference in controlled rate and
effective rate between the two groups.
As shown in Table 2, urinary protein quantity after
treatment for 4 and 12 weeks in the two groups was
significantly lower than that from before treatment. As
shown in Table 2, the curative effect in the treatment
group was better than that in the control group. How-
ever, there was no statistical difference in controlled
rate and effective rate between the two groups.
Analysis of adaptable subpopulation
To further study the subpopulation adaptable for this
therapy, the curative effect on patients weighing 30 kg
or less was analyzed. Among the 62 patients in the
treatment group were 39 males and 23 females.
Among the 22 patients in the control group were 17
males and 5 females. There were no statistical differenc-
es (P>0.05) in age or sex between the two groups.
As shown in Table 2, the curative effect was evaluated
for TCM syndromes, clinical effect, urinary protein,
and urinary red cells of patients weighing 30 kg or less.
After a 4-week treatment, the effective rate on TCM
syndromes (P=0.0096), the curative rate (P=0.0108)
and effective rate (P=0.0413) on clinical effect as well
as the curative rate on urinary protein (P=0.005) in the
treatment group were significantly better than those in
the control group. There were no statistical differences
among the remaining items. After a 12-week treat-
ment, there were no statistical differences in various in-
dexes of curative effect between the two groups.
Analysis of indexes of immunity and blood
coagulation
The improvement of immunoglobulin (Ig) series is
shown in Table 3.
The IgA of child HSPN patients exceeds the normal
Time
4 weeks
12 weeks
Group
Treatment group
Control group
χ2
P value
Treatment group
Control group
χ2
P value
Curative effect on
TCM syndromes
Clinical
curative
rate
6.50
3.57
0.6274
0.4283
36.59
17.86
6.3410
0.0118
Effective
rate
71.54
42.86
13.5220
0.0002
70.73
66.07
0.3926
0.5309
Clinical
curative
rate
22.76
12.50
2.5773
0.1084
30.89
30.36
0.0052
0.9424
Clinical curative
effect
Effective
rate
68.29
60.71
0.9838
0.3213
77.24
73.21
0.3410
0.5593
Curative effect on
urinary protein
Clinical
curative
rate
31.71
26.79
0.4424
0.5059
51.22
50.00
0.0229
0.8797
Effective
rate
69.11
75.00
0.6486
0.4206
81.30
83.93
0.1810
0.6705
Curative effect on
urinary red cells
Clinical
curative
rate
29.27
19.64
1.8413
0.1748
34.15
30.36
0.2500
0.6170
Effective
rate
51.22
44.64
0.6659
0.4145
56.10
51.79
0.2888
0.5910
Table 1 Comparison of curative effects between the two groups after treatment for 4 and 12 weeks (%)
Notes: treatment group were received Chinese medicinal orally, twice a day, 50 mL for patients weighing <20 kg, or 100 mL for patients
weighing ≥20 kg. Patients with hematuria in the control group took dipyridamole orally, 3-5 mg/kg-1·d-1. Patients with hematuria and pro-
teinuria took dipyridamole and captopril orally, 1-2 mg/kg-1·d-1. TCM: Traditional Chinese Medicine.
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reference value (0.7-2.3 g/L) and significantly declines
to normal after treatment in both groups (P<0.0001
for experimental group and P<0.0003 for control
group). IgG, IgM, and IgE of the patients were within
normal values. In the treatment group, IgE after treat-
ment was significantly lower than that before treat-
ment (P<0.0011). In the control group, IgE after treat-
ment did not improve. There were no statistical differ-
ences in various items between the two groups. The im-
provement in IgE may be related to the curative effect
on hematuria. The improvement in T-lymphocytic sub-
groups is shown in Table 4.
The total number of T-lymphocytic subgroups (CD3)
and naturally killed cells (NK-C) of the patients in the
treatment group increased and B-lymphocytes (BC) de-
creased after the 12-week treatment, with statistical dif-
ference from before to after treatment. The NK-C in-
creased and BC decreased in the control group, with
statistical difference before to after treatment. There
was no statistical difference between the two groups.
The improvement in blood-coagulating function is
shown in Table 5.
The baseline values of D-dimer (D-D) in both groups
exceeded the normal reference value (0.01-0.50 µg/
mL). The D-D after treatment in the treatment group
significantly declined. Fibrinogen in the two groups af-
ter the 12-week treatment was significantly reduced.
After treatment, prothrombin time (PT) decreased sig-
nificantly (P<0.0001) in the treatment group, but
showed no obvious changes in the control group. The
relationship between the improvement of blood-coagu-
lating index and curative effect indicate that the reduc-
tion in fibrinogen is positively related to urinary pro-
tein with relative coefficient 0.23 and P=0.035.
DISCUSSION
At present, no specific treatments with few side-effects
are available to treat purpura nephritis in children, a
type of secondary nephritis. In our previous studies on
the distribution of TCM types in child purpura nephri-
tis, we found that children mainly suffer from HSPN
with internal accumulation of damp-toxins in the early
stage. Damp-heat is related to the nephropathy im-
mune reaction.11 The pathogenesis of nephropathy in
TCM is characterized by the impairment of kidney by
damp-heat, an important factor causing and aggravat-
ing kidney damage. The nephropathy causes the im-
mune reaction to continuously occur while its abate-
ment alleviates the immune reaction.
Figure 1 Comparison of median 24 h urinary protein before
and after treatment in the two groups
A: experimental group treated with Chinese herbal medi-
cine twice a day, 50 mL for patients weighing <20 kg, or
100 mL for patients weighing ≥20 kg. B: control group, pa-
tients with hematuria took dipyridamole orally, 3-5 mg/kg-1·
d-1; Patients with hematuria and proteinuria took dipyridam-
ole and captopril orally, 1-2 mg/kg-1·d-1. Curative effect after
a 4 weeks treatment compared with prior treatment, aP<
0.05; curative effect after a 12 weeks treatment compared
with prior treatment, bP<0.05.
24
hu
rin
ary
pro
tei
n(
mg
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24
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b
b
Table 2 Comparison of curative effect on patients weighing 30 kg or less between the two groups (%)
Time
4 weeks
12 weeks
Group
Treatment group
Control group
χ2
P value
Treatment group
Control group
χ2
P value
Curative effect on TCM
syndromes
Clinical
curative rate
6.45
0.00
5.8046
0.5688
37.10
31.82
0.1971
0.6571
Effectiv
e rate
79.03
50.00
6.7065
0.0096
77.42
68.18
0.7390
0.3900
Clinical
curative
rate
29.03
0.00
6.4961
0.0108
32.26
40.91
0.5376
0.4634
Clinical curative
effect
Effective
rate
77.42
54.55
4.163
0.0413
82.26
81.82
0.0000
1.0000
Curative effect on
urinary protein
Clinical
curative
rate
41.94
9.09
7.8827
0.005
56.45
59.09
0.0462
0.8298
Effective
rate
79.03
81.82
0.0000
1.0000
87.10
95.45
0.4730
0.4916
Clinical
curative
rate
35.48
18.18
2.2745
0.1315
32.26
45.45
1.2317
0.2671
Curative effect on
urinary red cells
Effective
rate
59.68
40.91
2.3089
0.1286
56.45
68.18
0.9274
0.3355
Notes: treatment group were received Chinese medicinal orally, twice a day, 50 mL for patients weighing <20 kg, or 100 mL for patients
weighing ≥20 kg. Patients with hematuria in the control group took dipyridamole orally, 3-5 mg/kg-1·d-1. Patients with hematuria and pro-
teinuria took dipyridamole and captopril orally, 1-2 mg/kg-1·d-1. TCM: Traditional Chinese Medicine.
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Professor Xueyi Pei claims that the origin of child
HSPN is deficiency of spleen and kidney and stagna-
tion of damp-heat, and its superficiality is insufficiency
of lung Qi and invasion by pathogen. The acute stage
of HSPN, which manifests as exuberant damp-heat
and bleeding from blood-heat, is an excess and heat
syndrome. A long illness course manifests as further
damage to the spleen and kidney and blood stagnation
belongs to deficiency syndrome and stasis syndrome.
Based on the above-mentioned TCM theory, HSPN in
children is mainly caused by damp-heat and will fur-
ther impair spleen and kidney.8 According to the patho-
genesis of HSPN, removing heat, promoting diuresis,
nourishing kidney, and consolidating essence can treat
HSPN. Considering the physiological and pathological
characteristics of child patients, medicinal materials
were selected to be slightly purging and nourishing to
strengthen body resistance and eliminate pathogenic
factors.
Chinese herbs were used in this study to treat
damp-heat syndrome. After treatment for 4 and 12
weeks, the obvious decline in the total score of
damp-heat confirms that Chinese herbs have a good cu-
rative effect on alleviating syndromes and signs of
damp-heat in the acute stage (within 4 weeks) of the
disease. From TCM theory, the accumulation of damp-
ness can affect spleen function and deficiency of spleen
Qi causes failure of the body to absorb nutrients.
This study shows that after a 4-week treatment, the
clinically controlled rate of urinary protein in the Chi-
nese herb group is much higher than that in the West-
ern Medicine group. Moreover, the curative effect on
urinary red cells is less obvious than that on protein-
uria because the therapy may be adaptable to the patho-
genesis of urinary protein and inadaptable to that of he-
maturia. It is believed that hematuria is mainly caused
by obstruction of collaterals by stasis and heat. The
therapy puts more stress on clearing damp-heat and at-
taches less importance to removing heat from blood,
promoting blood circulation, or removing blood stasis.
However, this may clarify that internal accumulation
of damp-heat is the main syndrome of early-stage child
HSPN. With a long course of treatment, the improve-
ment in total score for syndromes and the total effec-
tive rate of urinary protein and urinary red cells were
higher in the Chinese herb group. This indicates that
the internal accumulation of damp-heat is the main
cause for lingering illness and the therapy of clearing
away heat, promoting diuresis, and removing heat
from blood should be adopted throughout the treat-
ment.
Immunological dysfunction in child HSPN patients
manifests as reduced levels of CD3, CD4, and NK-C,
and in lowered immunological function of cells. These
changes cause deficient inhibition of inflammatory cell
factors, abnormal activation of B-lymphocytes, immu-
nological hyperfunction of body fluids, secretion of
IgA, formation of IgA as a main immunological com-
Index
IgA (g/L)
IgG (g/L)
IgM (g/L)
IgE (IU/ML)
Time
Baseline
12 weeks
12 weeks vs baseline test statistics
P value
Baseline
12 weeks
12 weeks vs baseline test statistics
P value
Baseline
12 weeks
12 weeks vs baseline test statistics
P value
Baseline
12 weeks
12 weeks vs baseline test statistics
P value
Treatment group
median (Q1-Q3)
2.41 (1.72-2.83)
1.88 (1.37-2.47)
-1460b
<0.0001
8.71 (6.66-10.00)
8.85 (7.20-9.80)
191b
0.4058
1.24 (0.98-1.53)
1.21 (0.93-1.56)
-70b
0.7673
43.83 (22.42-118.95)
31.76 (15.63-96.21)
-727b
0.0011
Control group
median (Q1-Q3)
2.58 (1.86-3.07)
1.88 (1.55-2.36)
-198b
0.0003
8.94 (7.68-9.71)
9.03 (7.42-10.10)
88b
0.1172
1.35 (1.00-1.62)
1.33 (1.00-1.56)
98b
0.0941
57.03 (25.82-110.20)
58.40 (18.21-141.42)
-75b
0.1443
Test
statistics
1.0803a
0.4977a
-
-
0.8706a
0.7126a
-
-
1.0410a
0.5486a
-
-
0.9824a
1.1285a
-
-
P value
0.2800
0.6187
-
-
0.3840
0.4761
-
-
0.2979
0.5833
-
-
0.3259
0.2591
-
-
Notes: treatment group were received Chinese medicinal orally, twice a day, 50 mL for patients weighing <20 kg, or 100 mL for patients
weighing ≥20 kg. Patients in control group with hematuria took dipyridamole orally, 3-5 mg/kg-1·d-1; patients with hematuria and protein-
uria took dipyridamole and captopril orally, 1-2 mg/kg-1·d-1. IgA: immunoglobulin A; IgM: immunoglobulin M; IgG: immunoglobulin G;
IgE: immunoglobulin E. a: Z value of rank test; b: S value of rank test.
Table 3 Comparison of immunological indexes for Ig series between the two groups
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pound deposited on the vascular wall of the kidney,
and inflammatory changes in blood vessels.15-18 In addi-
tion, IgE obviously increases and an allergic reaction
takes place in children with HSPN.19 This study found
that there is a statistical difference in the decrease in
IgA, IgE, and B-cells and in the increase in CD3 and
NK-C after treatment in the two groups. The changes
in the treatment group were more obvious than those
in the control group. The improvement in IgE may be
related to the curative effect on hematuria, indicating
that the treatment may improve the immunity of cells
and body fluid. Moreover, the better curative effect in
the Chinese herb group may be related to the more ef-
fective regulation of body immunity.
Research has confirmed that secondary hyperfibrinoly-
sis and hypercoagulability exist at the acute stage of
HSPN20,21 and secondary fibrinolysis (FIB) and throm-
bosis will further damage the kidney. Higher levels of
D-D are an important marker of hypercoagulability
and hyperfibrinolysis. The higher the level of FIB and
D-D, the earlier the kidney damage, and the worse the
prognosis.22 Chinese herbs for promoting blood circula-
tion can better improve hypercoagulability and reduce
protein in child HSPN patients.23-25 Additionally, the
dampness-removing recipe can significantly reduce the
level of D-D and fibrinogen and improve fibrinolysis
and hypercoagulability. It also holds that the reduction
in fibrinogen is positively related to the curative effect
on urinary protein, conforming to the positive relation-
ship between FIB level in plasma and 24 h excretion of
urinary protein as confirmed in previous studies.26
This study indicates that the recipe for clearing away
heat, promoting diuresis, nourishing kidney, and con-
solidating essence is an effective therapy to treat child
Table 4 Comparison of improvement in immunological indexes for CD series between the two groups
Index
CD3 (%)
CD4 (%)
CD8 (%)
BC (%)
NK (%)
Time
Baseline
12 weeks
12 weeks-baseline
12 weeks vs baseline test statistics
P value
Baseline
12 weeks
12 weeks-baseline
12 weeks vs baseline test statistics
P value
Baseline
12 weeks
12 weeks-baseline
12 weeks vs baseline test statistics
P value
Baseline
12 weeks
12 weeks-baseline
12 weeks vs baseline test statistics
P value
Baseline
12 weeks
12 weeks-baseline
12 weeks vs baseline test statistics
P value
Treatment group
median (Q1-Q3)
70.50 (64.95-75.00)
72.25 (68.20-78.10)
2.10 (﹣1.90-6.60)
749c
0.0010
33.50 (28.10-38.50)
34.80 (29.60-38.50)
0.65 (﹣3.00-4.65)
291c
0.2272
28.90 (25.70-33.00)
29.65 (25.30-35.00)
0.05 (﹣1.70-3.60)
﹣0.23d
0.8153
16.30 (12.60-20.90)
12.40 (10.00-15.10)
﹣4.45 (﹣6.95--0.20)
-1439.5c
<0.0001
9.30 (5.60-13.30)
12.15 (9.00-16.00)
2.25 (﹣0.85-7.00)
972c
<0.0001
Control group
median (Q1-Q3)
70.55 (63.80-74.85)
72.60 (67.75-76.15)
2.40 (﹣3.20-6.70)
79c
0.1421
32.80 (29.55-38.20)
35.60 (31.25-38.75)
1.70 (﹣2.95-5.15)
73c
0.1761
28.20 (24.00-32.60)
29.20 (24.95-34.40)
-0.05 (﹣3.95-3.85)
-1.23d
0.2297
16.70 (11.90-22.55)
13.70 (10.80-15.85)
﹣4.45 (﹣10.10-0.30)
﹣177.5c
0.0003
7.95 (5.75-13.25)
12.40 (8.65-17.05)
3.20 (0.40-7.05)
169c
0.0003
Test
statistics
﹣0.4908a
﹣0.6519a
﹣0.2005b
-
-
﹣0.2571a
0.4592b
0.5549a
-
-
0.5673b
0.3946b
﹣0.4154a
-
-
0.4432a
1.1031a
-0.4421a
-
-
﹣0.4101a
0.4045a
﹣0.8055b
-
-
P
value
0.6236
0.5144
0.8414
-
-
0.7971
0.6469
0.5790
-
-
0.5713
0.6938
0.6778
-
-
0.6576
0.2700
0.6584
-
-
0.6818
0.6858
0.4222
-
-
Notes: treatment group were received Chinese medicinal orally, twice a day, 50 mL for patients weighing <20 kg, or 100 mL for patients
weighing ≥20 kg. Patients in control group with hematuria took dipyridamole orally, 3-5 mg/kg-1·d-1; patients with hematuria and protein-
uria took dipyridamole and captopril orally, 1-2 mg/kg-1·d-1. TCM: Traditional Chinese Medicine. BC: B-lymphocytes; NK: naturally
killed cells. a: Z value of rank test; b: t value of t-test; c: S value of rank test; d: t value of paired t test.
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HSPN patients with internal accumulation of
damp-heat. The treatment can improve syndromes of
damp-toxin, reduce proteinuria and hematuria, regu-
late immune function, improve hypercoagulability and
hyperfibrinolysis, and avoid the side-effects of Western
Medicine. After treatment for 4-12 weeks, the amelio-
rated illness condition was stable and the patients had
no obvious adverse reactions. The therapy is especially
suitable for treating proteinuria in children with
HSPN. The therapy has a better curative effect on chil-
dren aged less than 13 years and weighing less than 30 kg
because the older the child is, the more frequently the
purpura relapses, and the more severe the illness con-
dition becomes. This severity causes more renal dys-
function,27 and HSPN becomes more difficult to
treat. The poor curative effect on older and heavier
children may be related to insufficient dosage of the
Chinese herb. Therefore, it is necessary to further ex-
plore the dosages of Chinese herbs and establish a de-
tailed treatment standard to facilitate TCM populariza-
tion and application.
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